Pain Management and Surgical Devices Global Market - Forecast to 2025
Pain is a debilitating condition, which can arise from arthritis, cancer, fibromyalgia and trauma, which includes neuropathic pain and nociceptive pain. This report focuses on treating various pain conditions with electrotherapy devices, ablation devices and surgical procedures. Electrotherapy devices include Spinal cord stimulator, peripheral nerve stimulator, TENS and NMES devices. These devices use electricity to treat pain by blocking the pain signals passing from nerve to brain. Surgical procedures such as kyphoplasty and vertebroplasty are used to treat pain caused by degenerative disc disease, whereas ablation procedures such as Radiofrequency ablation and Cryoablation are used to treat chronic pain and cancer pain by damaging pain causing nerve tissue. Ablation procedure damages the nerve that causes the pain and stops the transmission of pain signals to the brain. Several other devices like spacers, screws and artificial discs are used to treat back pain and neck pain caused by degenerative disc disease.
According to IQ4I analysis, the pain management and surgical devices global market is expected to grow at a high single digit CAGR to reach $8,824.7 million by 2025. The pain management and surgical devices market is mainly segmented by products, treatment type, application, end-users and by geography.
Based on the products market is segmented into pain devices and pain surgery, among this pain devices accounted the largest revenue in 2018 and is expected to grow at a high single digit CAGR from 2018 to 2025. Pain devices segment is further classified into internal pain devices and external pain devices. Among the internal pain devices, spinal cord stimulator accounted the largest revenue in 2018 and is projected to grow at a high single digit CAGR from 2018 to 2025. Among the external pain devices, TENS is accounted for largest revenue in 2018 and is expected to grow at a low single digit CAGR from 2018 to 2025, other external pain device segment include ultrasound therapy, photobiomodulation therapy, microwave therapy, short wave therapy, vegus nerve stimulation therapy and is expected to grow at a low single digit CAGR from 2018 to 2025. Pain surgery segment is divided into Kyphoplasty and vertebroplasty, fixation devices, artificial disc replacement and ablation. Among this kyphoplasty and vertebroplasty accounted the largest revenue in 2018 and is expected to grow at a mid single digit CAGR from 2018 to 2025, artificial disc replacement is projected to grow at a high single digit CAGR from 2018 to 2025. In pain surgery, ablation segment is further classified into radiofrequency ablation and cryoablation. Among this, radiofrequency ablation accounted the largest revenue and is projected to grow at a mid single digit CAGR from 2018 to 2025. Cryoablation is expected to grow at a high single digit CAGR from 2018 to 2025.
Based on the treatment type, pain management and surgical devices are classified into Invasive and non invasive. Among this, invasive devices accounted the largest revenue in 2018 and expected to grow at a high single digit CAGR from 2018 to 2025.
The applications segment in the pain management and surgical device market is classified into neuropathic pain, cancer pain, failed back surgery syndrome (FBSS), musculoskeletal disorder (MSD) and other pain, Among these applications, MSD holds the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025, due to increase in incidence of musculoskeletal disorders.
Based on end-users, pain management and surgical devices market is segmented into hospitals, ambulatory surgical centers, pain management centers and others. In this segment, hospitals held the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025.
Pain management and surgical devices geographic market is segmented into four major regions namely North America, Europe, Asia Pacific and Rest of World (ROW). North American region commanded the largest revenue in 2018 and expected to grow at a mid single digit CAGR. However, Asia-Pacific is expected to grow at high single digit CAGR from 2018 to 2025.
Major players in pain management devices and surgical devices are Abbot Laboratories (U.S.), Boston Scientific (U.S.), Medtronic Inc. (Ireland), Avanos Medical Inc. (Halyard health Inc.) (U.S.), Nevrocorp (U.S.), Nuvectra corporation (U.S.), Stryker Corporation (U.S.), Johnson and Johnson (DePuy synthes), (U.S.), Merit medicals (U.S.), DJO Finance Ltd. (Chattanooga) (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
According to IQ4I analysis, the pain management and surgical devices global market is expected to grow at a high single digit CAGR to reach $8,824.7 million by 2025. The pain management and surgical devices market is mainly segmented by products, treatment type, application, end-users and by geography.
Based on the products market is segmented into pain devices and pain surgery, among this pain devices accounted the largest revenue in 2018 and is expected to grow at a high single digit CAGR from 2018 to 2025. Pain devices segment is further classified into internal pain devices and external pain devices. Among the internal pain devices, spinal cord stimulator accounted the largest revenue in 2018 and is projected to grow at a high single digit CAGR from 2018 to 2025. Among the external pain devices, TENS is accounted for largest revenue in 2018 and is expected to grow at a low single digit CAGR from 2018 to 2025, other external pain device segment include ultrasound therapy, photobiomodulation therapy, microwave therapy, short wave therapy, vegus nerve stimulation therapy and is expected to grow at a low single digit CAGR from 2018 to 2025. Pain surgery segment is divided into Kyphoplasty and vertebroplasty, fixation devices, artificial disc replacement and ablation. Among this kyphoplasty and vertebroplasty accounted the largest revenue in 2018 and is expected to grow at a mid single digit CAGR from 2018 to 2025, artificial disc replacement is projected to grow at a high single digit CAGR from 2018 to 2025. In pain surgery, ablation segment is further classified into radiofrequency ablation and cryoablation. Among this, radiofrequency ablation accounted the largest revenue and is projected to grow at a mid single digit CAGR from 2018 to 2025. Cryoablation is expected to grow at a high single digit CAGR from 2018 to 2025.
Based on the treatment type, pain management and surgical devices are classified into Invasive and non invasive. Among this, invasive devices accounted the largest revenue in 2018 and expected to grow at a high single digit CAGR from 2018 to 2025.
The applications segment in the pain management and surgical device market is classified into neuropathic pain, cancer pain, failed back surgery syndrome (FBSS), musculoskeletal disorder (MSD) and other pain, Among these applications, MSD holds the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025, due to increase in incidence of musculoskeletal disorders.
Based on end-users, pain management and surgical devices market is segmented into hospitals, ambulatory surgical centers, pain management centers and others. In this segment, hospitals held the highest share in 2018, and expected to grow at a high single digit CAGR from 2018 to 2025.
Pain management and surgical devices geographic market is segmented into four major regions namely North America, Europe, Asia Pacific and Rest of World (ROW). North American region commanded the largest revenue in 2018 and expected to grow at a mid single digit CAGR. However, Asia-Pacific is expected to grow at high single digit CAGR from 2018 to 2025.
Major players in pain management devices and surgical devices are Abbot Laboratories (U.S.), Boston Scientific (U.S.), Medtronic Inc. (Ireland), Avanos Medical Inc. (Halyard health Inc.) (U.S.), Nevrocorp (U.S.), Nuvectra corporation (U.S.), Stryker Corporation (U.S.), Johnson and Johnson (DePuy synthes), (U.S.), Merit medicals (U.S.), DJO Finance Ltd. (Chattanooga) (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
- North America
- U.S.
- Rest of North America
- Europe
- Germany
- France
- U.K.
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of APAC
- Rest of the World (RoW)
- Brazil
- Rest of Latin America
- Middle East and Others
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Rise in chronic diseases and pain disorders
3.3.1.2 Adverse effects of pain medicines and stringent regulations to limits opioids medicine
3.3.1.3 Increase in a geriatric population with chronic pain
3.3.1.4 Technological advancement
3.3.1.5 Reimbursement in pain management devices
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Availability of alternative therapies
3.3.2.2 Contraindications of pain management devices
3.3.2.3 High cost of pain management devices
3.3.2.4 Stringent regulations for the approvals of products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 quality management system
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 JAPAN
3.4.6 CHINA
3.4.7 INDIA
3.5 PATENT TRENDS
3.5.1 INTRODUCTION
3.5.2 PAIN MANAGEMENT AND SURGICAL DEVICES PATENT TREND
3.6 TECHNOLOGICAL ADVANCEMENTS
3.6.1 INTRODUCTION
3.6.2 NANO-ELECTRODES AND WIRELESS TECHNOLOGY FOR NEUROMODULATION
3.6.3 POINT OF CARE ULTRASOUND (POCUS) NEUROMODULATION
3.6.4 MINIATURIZATION OF PAIN MANAGEMENT DEVICES
3.6.5 TECHNOLOGICAL CONVERGENCE OF PAIN MANAGEMENT DEVICES
3.7 PORTER’S FIVE FORCE ANALYSIS
3.7.1 THREAT OF NEW ENTRANTS
3.7.2 THREAT OF SUBSTITUTES
3.7.3 BARGAINING POWER OF SUPPLIERS
3.7.4 BARGAINING POWER OF BUYERS
3.7.5 COMPETITIVE RIVALRY
3.8 SUPPLY CHAIN ANALYSIS
3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.9.1 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE ANALYSIS
3.9.2 MARKET SHARE ANALYSIS OF SPINAL CORD STIMULATOR BY MAJOR PLAYERS
3.9.3 MARKET SHARE ANALYSIS OF RADIOFREQUENCY ABLATION DEVICES BY MAJOR PLAYERS
3.9.4 MARKET SHARE ANALYSIS OF KYPHOPLASTY AND VERTEBROPLASTY DEVICES BY MAJOR PLAYERS
3.10 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET PENETRATION AND NUMBER OF UNIT SOLD
3.10.1 PAIN MANAGEMENT AND SURGICAL DEVICES MARKET PENETRATION
3.11 PAIN MANAGEMNENT AND SURGICAL DEVICES NUMBER OF UNITS BY REGION
3.11.1 SPINAL CORD STIMULATOR NUMBER OF UNITS BY REGION (2017-2025) (NO’S)
3.11.2 RADIOFREQUENCY ABLATIO DEVICES NUMBER OF UNITS BY REGION
3.11.3 ARTIFICIAL DISC REPLACEMENT DEVICES NUMBER OF UNITS BY REGION
3.12 PAIN MANAGEMENT AND SURGICAL DEVICES COMPANY COMPARISON BY PRODUCTS
3.12.1 SPINAL CORD STIMULATOR DEVICES
3.12.2 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR (TENS)
3.12.3 ABLATION DEVICES
3.12.4 KYPHOPLASTY & VERTEBROPLASTY
3.12.5 FIXATION DEVICES AND ARTIFICIAL DISC REPLACEMENT
3.12.6 OTHER PAIN MANAGEMENT DEVICES
4 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 PAIN DEVICES
4.2.1 INTERNAL PAIN DEVICES
4.2.1.1 Spinal cord stimulator
4.2.1.2 Peripheral nerve stimulator
4.2.1.3 Other internal pain devices
4.2.2 EXTERNAL PAIN DEVICES
4.2.2.1 Transcutaneous electrical nerve stimulation (TENS)
4.2.2.2 Neuromuscular electrical stimulation (NMES)
4.2.2.3 Other external pain devices
4.2.2.3.1 Ultrasound
4.2.2.3.2 Photobiomodulation therapy
4.2.2.3.3 Other therapy
4.3 PAIN SURGERY
4.3.1 KYPHOPLASTY & VERTEBROPLASTY
4.3.2 FIXATION DEVICES
4.3.3 ARTIFICIAL DISC REPLACEMENT
4.3.4 ABLATION
4.3.4.1 Radiofrequency ablation
4.3.4.2 Cryoablation
5 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY TREATMENT TYPE
5.1 INTRODUCTION
5.2 INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES
5.3 NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES
6 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 NEUROPATHIC PAIN
6.3 CANCER PAIN
6.4 FAILED BACK SURGERY SYNDROME (FBSS)
6.5 MUSCULOSKELETAL DISORDERS (MSD)
6.6 OTHER PAIN
7 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY END-USERS
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 AMBULATORY SURGERY CENTER
7.4 PAIN MANAGEMENT CENTERS & OTHERS
8 REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 REST OF NORTH AMERICA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 U.K.
8.3.4 REST OF EUROPE
8.4 APAC
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 REST OF APAC
8.5 ROW
8.5.1 BRAZIL
8.5.2 REST OF LATAM
8.5.3 MIDDLE EAST & OTHERS
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 APPROVALS
9.3 NEW PRODUCT LAUNCH
9.4 MERGERS AND ACQUISITIONS
10 MAJOR COMPANIES
10.1 ABBOTT LABORATORIES
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 AVANOS MEDICAL, INC. (HALYARD HEALTH, INC.)
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 BOSTON SCIENTIFIC CORPOARTION
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 DJO GLOBAL
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 JOHNSON AND JOHNSON
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 MEDTRONIC, PLC
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 MERIT MEDICALS SYSTEM INC.
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 NEVROCORP
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 NUVECTRA
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 STRYKER CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Rise in chronic diseases and pain disorders
3.3.1.2 Adverse effects of pain medicines and stringent regulations to limits opioids medicine
3.3.1.3 Increase in a geriatric population with chronic pain
3.3.1.4 Technological advancement
3.3.1.5 Reimbursement in pain management devices
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Availability of alternative therapies
3.3.2.2 Contraindications of pain management devices
3.3.2.3 High cost of pain management devices
3.3.2.4 Stringent regulations for the approvals of products
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 quality management system
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 JAPAN
3.4.6 CHINA
3.4.7 INDIA
3.5 PATENT TRENDS
3.5.1 INTRODUCTION
3.5.2 PAIN MANAGEMENT AND SURGICAL DEVICES PATENT TREND
3.6 TECHNOLOGICAL ADVANCEMENTS
3.6.1 INTRODUCTION
3.6.2 NANO-ELECTRODES AND WIRELESS TECHNOLOGY FOR NEUROMODULATION
3.6.3 POINT OF CARE ULTRASOUND (POCUS) NEUROMODULATION
3.6.4 MINIATURIZATION OF PAIN MANAGEMENT DEVICES
3.6.5 TECHNOLOGICAL CONVERGENCE OF PAIN MANAGEMENT DEVICES
3.7 PORTER’S FIVE FORCE ANALYSIS
3.7.1 THREAT OF NEW ENTRANTS
3.7.2 THREAT OF SUBSTITUTES
3.7.3 BARGAINING POWER OF SUPPLIERS
3.7.4 BARGAINING POWER OF BUYERS
3.7.5 COMPETITIVE RIVALRY
3.8 SUPPLY CHAIN ANALYSIS
3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.9.1 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE ANALYSIS
3.9.2 MARKET SHARE ANALYSIS OF SPINAL CORD STIMULATOR BY MAJOR PLAYERS
3.9.3 MARKET SHARE ANALYSIS OF RADIOFREQUENCY ABLATION DEVICES BY MAJOR PLAYERS
3.9.4 MARKET SHARE ANALYSIS OF KYPHOPLASTY AND VERTEBROPLASTY DEVICES BY MAJOR PLAYERS
3.10 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET PENETRATION AND NUMBER OF UNIT SOLD
3.10.1 PAIN MANAGEMENT AND SURGICAL DEVICES MARKET PENETRATION
3.11 PAIN MANAGEMNENT AND SURGICAL DEVICES NUMBER OF UNITS BY REGION
3.11.1 SPINAL CORD STIMULATOR NUMBER OF UNITS BY REGION (2017-2025) (NO’S)
3.11.2 RADIOFREQUENCY ABLATIO DEVICES NUMBER OF UNITS BY REGION
3.11.3 ARTIFICIAL DISC REPLACEMENT DEVICES NUMBER OF UNITS BY REGION
3.12 PAIN MANAGEMENT AND SURGICAL DEVICES COMPANY COMPARISON BY PRODUCTS
3.12.1 SPINAL CORD STIMULATOR DEVICES
3.12.2 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATOR (TENS)
3.12.3 ABLATION DEVICES
3.12.4 KYPHOPLASTY & VERTEBROPLASTY
3.12.5 FIXATION DEVICES AND ARTIFICIAL DISC REPLACEMENT
3.12.6 OTHER PAIN MANAGEMENT DEVICES
4 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 PAIN DEVICES
4.2.1 INTERNAL PAIN DEVICES
4.2.1.1 Spinal cord stimulator
4.2.1.2 Peripheral nerve stimulator
4.2.1.3 Other internal pain devices
4.2.2 EXTERNAL PAIN DEVICES
4.2.2.1 Transcutaneous electrical nerve stimulation (TENS)
4.2.2.2 Neuromuscular electrical stimulation (NMES)
4.2.2.3 Other external pain devices
4.2.2.3.1 Ultrasound
4.2.2.3.2 Photobiomodulation therapy
4.2.2.3.3 Other therapy
4.3 PAIN SURGERY
4.3.1 KYPHOPLASTY & VERTEBROPLASTY
4.3.2 FIXATION DEVICES
4.3.3 ARTIFICIAL DISC REPLACEMENT
4.3.4 ABLATION
4.3.4.1 Radiofrequency ablation
4.3.4.2 Cryoablation
5 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY TREATMENT TYPE
5.1 INTRODUCTION
5.2 INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES
5.3 NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES
6 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 NEUROPATHIC PAIN
6.3 CANCER PAIN
6.4 FAILED BACK SURGERY SYNDROME (FBSS)
6.5 MUSCULOSKELETAL DISORDERS (MSD)
6.6 OTHER PAIN
7 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET, BY END-USERS
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 AMBULATORY SURGERY CENTER
7.4 PAIN MANAGEMENT CENTERS & OTHERS
8 REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 REST OF NORTH AMERICA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 U.K.
8.3.4 REST OF EUROPE
8.4 APAC
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 REST OF APAC
8.5 ROW
8.5.1 BRAZIL
8.5.2 REST OF LATAM
8.5.3 MIDDLE EAST & OTHERS
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 APPROVALS
9.3 NEW PRODUCT LAUNCH
9.4 MERGERS AND ACQUISITIONS
10 MAJOR COMPANIES
10.1 ABBOTT LABORATORIES
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 AVANOS MEDICAL, INC. (HALYARD HEALTH, INC.)
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 BOSTON SCIENTIFIC CORPOARTION
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 DJO GLOBAL
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 JOHNSON AND JOHNSON
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 MEDTRONIC, PLC
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 MERIT MEDICALS SYSTEM INC.
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 NEVROCORP
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 NUVECTRA
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 STRYKER CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 2 SPINAL CORD STIMULATORS NUMBER OF UNITS, BY REGION, (2017-2025) (NO’S)
Table 3 RADIOFREQUENCY ABLATION DEVICES NUMBER OF UNITS, BY REGION, (2017-2025) (NO’S)
Table 4 ARTIFICIAL DISC REPLACEMETN DEVICES NUMBER OF UNITS, BY REGION, (2017-2025) (NO’S)
Table 5 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 6 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 7 PAIN DEVICES GLOBAL MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 8 PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 9 INTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 10 INTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 11 SPINAL CORD STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 12 PERIPHERAL NERVE STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 13 OTHER INTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 14 EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 15 EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 16 TENS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 17 NMES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 18 OTHER EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 19 OTHER EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 20 ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 21 PHOTOBIOMODULATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 22 OTHER DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 23 PAIN SURGERY GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 24 PAIN SURGERY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 25 KYPHOPLASTY & VERTEBROPLASTY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 26 FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 27 ARTIFICIAL DISC REPLACEMENT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 28 ABLATION GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 29 ABLATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 30 RADIOFREQUENCY ABLATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 31 CRYOABLATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 32 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 33 INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 34 NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 35 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 36 NEUROPATHIC PAIN GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 37 CANCER PAIN GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 38 FAILED BACK SURGERY SYNDROME GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 39 MUSCULOSKELETAL DISORDERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 40 OTHER PAIN GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 41 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 42 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 43 AMBULATORY SURGERY CENTER GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 44 PAIN MANAGEMENT CENTERS & OTHERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 45 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 46 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 47 NORTH AMERICA PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 48 NORTH AMERICA INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 49 NORTH AMERICA EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 50 NORTH AMERICA OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 51 NORTH AMERICA PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 52 NORTH ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 53 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 54 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 55 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 56 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
Table 57 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 58 EUROPE PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 59 EUROPE INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 60 EUROPE EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 61 EUROPE OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 62 EUROPE PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 63 EUROPE ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 64 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 65 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 66 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 67 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
Table 68 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 69 APAC PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 70 APAC INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 71 APAC EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 72 APAC OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 73 APAC PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 74 APAC ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 75 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 76 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 77 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 78 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
Table 79 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 80 ROW PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 81 ROW INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 82 ROW EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 83 ROW OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 84 ROW PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 85 ROW ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 86 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 87 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 88 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 89 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
Table 90 APPROVALS (2016-2018)
Table 91 NEW PRODUCT LAUNCHES (2016-2018)
Table 92 MERGERS AND ACQUISITIONS (2016-2018)
Table 93 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 94 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
Table 95 ABBOTT LABORATORIES: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
Table 96 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
Table 97 AVANOS MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 98 AVANOS MEDICAL, INC.: TOTAL REVENUE, BY REGION, (2016-2018) ($MN)
Table 99 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 100 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
Table 101 BOSTON SCIENTIFIC CORPORATION:REVENUE BY MEDICAL SURGERY, (2016-2018) ($MN)
Table 102 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
Table 103 DJO GLOBAL: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 104 DJO GLOBAL: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
Table 105 DJO GLOBAL: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
Table 106 JOHNSON AND JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 107 JOHNSON AND JOHNSON: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
Table 108 JOHNSON AND JOHNSON: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
Table 109 JOHNSON AND JOHNSON: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
Table 110 JOHNSON AND JOHNSON: TOTAL REVENUE BY REGION, (2016-2018) ($MN)
Table 111 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 112 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 113 MEDTRONIC, PLC: RESTORATIVE THERAPIES TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN)
Table 114 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
Table 115 MERIT MEDICAL SYSTEM INC.: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 116 MERIT MEDICALS SYSTEMS INC.: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
Table 117 MERIT MEDICAL SYSTEM INC.: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
Table 118 NEVROCORP : TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 119 NEVROCORP: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
Table 120 NUVECTRA CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 121 NUVECTRA CORPORATION : TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
Table 122 NUVECTRA CORPORATION : TOTAL REVENUE, BY PRODUCT SEGMENTS, (2016-2018) ($MN)
Table 123 NUVECTRA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
Table 124 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 125 STRYKER CORPORATION: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
Table 126 STRYKER CORPORATION: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
Table 127 STRYKER CORPORATION: TOTAL REVENUE BY REGION, (2016-2018) ($MN)
Table 1 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 2 SPINAL CORD STIMULATORS NUMBER OF UNITS, BY REGION, (2017-2025) (NO’S)
Table 3 RADIOFREQUENCY ABLATION DEVICES NUMBER OF UNITS, BY REGION, (2017-2025) (NO’S)
Table 4 ARTIFICIAL DISC REPLACEMETN DEVICES NUMBER OF UNITS, BY REGION, (2017-2025) (NO’S)
Table 5 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 6 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 7 PAIN DEVICES GLOBAL MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 8 PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 9 INTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 10 INTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 11 SPINAL CORD STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 12 PERIPHERAL NERVE STIMULATOR GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 13 OTHER INTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 14 EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 15 EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 16 TENS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 17 NMES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 18 OTHER EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 19 OTHER EXTERNAL PAIN DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 20 ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 21 PHOTOBIOMODULATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 22 OTHER DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 23 PAIN SURGERY GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 24 PAIN SURGERY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 25 KYPHOPLASTY & VERTEBROPLASTY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 26 FIXATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 27 ARTIFICIAL DISC REPLACEMENT DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 28 ABLATION GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 29 ABLATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 30 RADIOFREQUENCY ABLATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 31 CRYOABLATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 32 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 33 INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 34 NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 35 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 36 NEUROPATHIC PAIN GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 37 CANCER PAIN GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 38 FAILED BACK SURGERY SYNDROME GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 39 MUSCULOSKELETAL DISORDERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 40 OTHER PAIN GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 41 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 42 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 43 AMBULATORY SURGERY CENTER GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 44 PAIN MANAGEMENT CENTERS & OTHERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 45 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
Table 46 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 47 NORTH AMERICA PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 48 NORTH AMERICA INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 49 NORTH AMERICA EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 50 NORTH AMERICA OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 51 NORTH AMERICA PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 52 NORTH ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 53 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 54 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 55 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 56 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
Table 57 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 58 EUROPE PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 59 EUROPE INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 60 EUROPE EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 61 EUROPE OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 62 EUROPE PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 63 EUROPE ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 64 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 65 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 66 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 67 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
Table 68 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 69 APAC PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 70 APAC INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 71 APAC EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 72 APAC OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 73 APAC PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 74 APAC ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 75 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 76 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 77 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 78 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
Table 79 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
Table 80 ROW PAIN DEVICES MARKET REVENUE, BY SITE, (2017-2025) ($MN)
Table 81 ROW INTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 82 ROW EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 83 ROW OTHER EXTERNAL PAIN DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 84 ROW PAIN SURGERY MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 85 ROW ABLATION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
Table 86 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE, (2017-2025) ($MN)
Table 87 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
Table 88 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY END-USERS, (2017-2025) ($MN)
Table 89 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
Table 90 APPROVALS (2016-2018)
Table 91 NEW PRODUCT LAUNCHES (2016-2018)
Table 92 MERGERS AND ACQUISITIONS (2016-2018)
Table 93 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 94 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
Table 95 ABBOTT LABORATORIES: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
Table 96 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
Table 97 AVANOS MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 98 AVANOS MEDICAL, INC.: TOTAL REVENUE, BY REGION, (2016-2018) ($MN)
Table 99 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 100 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
Table 101 BOSTON SCIENTIFIC CORPORATION:REVENUE BY MEDICAL SURGERY, (2016-2018) ($MN)
Table 102 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
Table 103 DJO GLOBAL: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 104 DJO GLOBAL: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
Table 105 DJO GLOBAL: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
Table 106 JOHNSON AND JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 107 JOHNSON AND JOHNSON: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
Table 108 JOHNSON AND JOHNSON: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
Table 109 JOHNSON AND JOHNSON: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
Table 110 JOHNSON AND JOHNSON: TOTAL REVENUE BY REGION, (2016-2018) ($MN)
Table 111 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 112 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 113 MEDTRONIC, PLC: RESTORATIVE THERAPIES TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN)
Table 114 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
Table 115 MERIT MEDICAL SYSTEM INC.: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 116 MERIT MEDICALS SYSTEMS INC.: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
Table 117 MERIT MEDICAL SYSTEM INC.: TOTAL REVENUE BY GEOGRAPHY, (2016-2018) ($MN)
Table 118 NEVROCORP : TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 119 NEVROCORP: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
Table 120 NUVECTRA CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 121 NUVECTRA CORPORATION : TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
Table 122 NUVECTRA CORPORATION : TOTAL REVENUE, BY PRODUCT SEGMENTS, (2016-2018) ($MN)
Table 123 NUVECTRA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
Table 124 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
Table 125 STRYKER CORPORATION: TOTAL REVENUE BY SEGMENTS, (2016-2018) ($MN)
Table 126 STRYKER CORPORATION: TOTAL REVENUE BY SUB SEGMENTS, (2016-2018) ($MN)
Table 127 STRYKER CORPORATION: TOTAL REVENUE BY REGION, (2016-2018) ($MN)
LIST OF FIGURES
Figure 1 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
Figure 2 RESEARCH METHODOLOGY: PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET
Figure 3 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: FORECASTING MODEL
Figure 5 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
Figure 6 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 PAIN MANAGEMENT AND SURGICAL DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2013–2018)
Figure 9 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
Figure 10 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 11 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
Figure 12 SPINAL CORD STIMULATOR GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
Figure 13 RADIOFREQUENCY ABLATION GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
Figure 14 KYPHOPLASTY AND VERTEBROPLASTY DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
Figure 15 PAIN MANAGEMENT AND SURGICAL DEVICES MARKET PENETRATION IN GLOBAL PAIN MANAGEMENT MARKET, 2018 (%)
Figure 16 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2018 V/S 2025) (%)
Figure 17 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY REGION (2018 V/S 2025) (%)
Figure 18 PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 19 PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 20 INTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 21 INTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 22 OTHER INTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 23 EXTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 24 EXTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 25 OTHER EXTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 26 PAIN SURGERY GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2018 V/S 2025) (%)
Figure 27 PAIN SURGERY GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 28 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY TREATMENT TYPE (2018 V/S 2025) (%)
Figure 29 INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 30 NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 31 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY APPLICATION (2018 V/S 2025) (%)
Figure 32 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY END-USERS (2018 V/S 2025) (%)
Figure 33 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN), CAGR (%)
Figure 34 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY GEOGRAPHY (2018) (%)
Figure 35 NORTH AMERICA INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 36 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
Figure 37 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
Figure 38 U.S. PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 39 U.S. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 40 U.S. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 41 REST OF NORTH AMERICA PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 42 REST OF NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 43 REST OF NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 44 EUROPE INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 45 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
Figure 46 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
Figure 47 GERMANY PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 48 GERMANY PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 49 GERMANY PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 50 FRANCE PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 51 FRANCE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 52 FRANCE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 53 U.K. PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 54 U.K. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 55 U.K. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 56 REST OF EUROPE PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 57 REST OF EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 58 REST OF EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 59 APAC INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 60 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
Figure 61 APAC PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
Figure 62 JAPAN PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 63 JAPAN PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 64 JAPAN PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 65 CHINA PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 66 CHINA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 67 CHINA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 68 INDIA PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 69 INDIA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 70 INDIA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 71 REST OF APAC PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 72 REST OF APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 73 REST OF APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 74 ROW INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 75 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
Figure 76 ROW PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
Figure 77 BRAZIL PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 78 BRAZIL PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 79 BRAZIL PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 80 REST OF LATAM PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 81 REST OF LATAM PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 82 REST OF LATAM PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 83 MIDDLE EAST & OTHERS PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 84 MIDDLE EAST & OTHERS PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 85 MIDDLE EAST & OTHERS PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 86 KEY GROWTH STRATEGIES, (2016-2018)
Figure 87 SWOT: ABBOTT LABORATORIES
Figure 88 SWOT: AVANOS MEDICAL, INC.
Figure 89 SWOT: BOSTON SCIENTIFIC CORPORATION
Figure 90 SWOT: DJO GLOBAL
Figure 91 SWOT: JOHNSON AND JOHNSON
Figure 92 SWOT: MEDTRONIC, PLC
Figure 93 SWOT: MERIT MEDICALS SYSTEMS, INC.
Figure 94 SWOT: NEVROCORP
Figure 95 SWOT: NUVECTRA
Figure 96 SWOT: STRYKER CORPORATION
Figure 1 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
Figure 2 RESEARCH METHODOLOGY: PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET
Figure 3 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: FORECASTING MODEL
Figure 5 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
Figure 6 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 PAIN MANAGEMENT AND SURGICAL DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2013–2018)
Figure 9 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
Figure 10 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 11 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
Figure 12 SPINAL CORD STIMULATOR GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
Figure 13 RADIOFREQUENCY ABLATION GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
Figure 14 KYPHOPLASTY AND VERTEBROPLASTY DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 (%)
Figure 15 PAIN MANAGEMENT AND SURGICAL DEVICES MARKET PENETRATION IN GLOBAL PAIN MANAGEMENT MARKET, 2018 (%)
Figure 16 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2018 V/S 2025) (%)
Figure 17 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY REGION (2018 V/S 2025) (%)
Figure 18 PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 19 PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 20 INTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 21 INTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 22 OTHER INTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 23 EXTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 24 EXTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 25 OTHER EXTERNAL PAIN DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 26 PAIN SURGERY GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2018 V/S 2025) (%)
Figure 27 PAIN SURGERY GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 28 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY TREATMENT TYPE (2018 V/S 2025) (%)
Figure 29 INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 30 NON-INVASIVE PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY REGION, (2018 V/S 2025) (%)
Figure 31 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY APPLICATION (2018 V/S 2025) (%)
Figure 32 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY END-USERS (2018 V/S 2025) (%)
Figure 33 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN), CAGR (%)
Figure 34 PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET SHARE, BY GEOGRAPHY (2018) (%)
Figure 35 NORTH AMERICA INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 36 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
Figure 37 NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
Figure 38 U.S. PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 39 U.S. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 40 U.S. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 41 REST OF NORTH AMERICA PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 42 REST OF NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 43 REST OF NORTH AMERICA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 44 EUROPE INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 45 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
Figure 46 EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
Figure 47 GERMANY PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 48 GERMANY PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 49 GERMANY PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 50 FRANCE PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 51 FRANCE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 52 FRANCE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 53 U.K. PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 54 U.K. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 55 U.K. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 56 REST OF EUROPE PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 57 REST OF EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 58 REST OF EUROPE PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 59 APAC INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 60 APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
Figure 61 APAC PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
Figure 62 JAPAN PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 63 JAPAN PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 64 JAPAN PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 65 CHINA PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 66 CHINA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 67 CHINA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 68 INDIA PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 69 INDIA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 70 INDIA PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 71 REST OF APAC PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 72 REST OF APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 73 REST OF APAC PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 74 ROW INTERNAL AND EXTERNAL PAIN DEVICES, PAIN SURGERY AND ABLATION MARKET SHARE, BY PRODUCT TYPE (2018 V/S 2025) (%)
Figure 75 ROW PAIN MANAGEMENT AND SURGICAL DEVICES MARKET SHARE, BY APPLICATION (2018) (%), CAGR (%) AND END-USER (2018 V/S 2025) (%)
Figure 76 ROW PAIN MANAGEMENT AND SURGICAL DEVICES SHARE, BY COUNTRY (2018 V/S 2025) (%)
Figure 77 BRAZIL PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 78 BRAZIL PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 79 BRAZIL PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 80 REST OF LATAM PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 81 REST OF LATAM PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 82 REST OF LATAM PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 83 MIDDLE EAST & OTHERS PMSD MARKET, BY PRODUCT, PAIN DEVICES BY SITE, INTERNAL PAIN DEVICES, PAIN SURGERY BY PRODUCT TYPE (2018 V/S 2025) ($MN)
Figure 84 MIDDLE EAST & OTHERS PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY TREATMENT TYPE AND END-USER (2018 V/S 2025) ($MN)
Figure 85 MIDDLE EAST & OTHERS PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
Figure 86 KEY GROWTH STRATEGIES, (2016-2018)
Figure 87 SWOT: ABBOTT LABORATORIES
Figure 88 SWOT: AVANOS MEDICAL, INC.
Figure 89 SWOT: BOSTON SCIENTIFIC CORPORATION
Figure 90 SWOT: DJO GLOBAL
Figure 91 SWOT: JOHNSON AND JOHNSON
Figure 92 SWOT: MEDTRONIC, PLC
Figure 93 SWOT: MERIT MEDICALS SYSTEMS, INC.
Figure 94 SWOT: NEVROCORP
Figure 95 SWOT: NUVECTRA
Figure 96 SWOT: STRYKER CORPORATION
